基于FAERS数据库的唑吡坦性别差异不良反应信号挖掘与分析OA
Gender-specific adverse drug reaction signal mining of zolpidem using the FAERS database
目的:探究并评估唑吡坦在不同性别患者间产生的药品不良反应信号(Adverse drug reaction,ADR)的差异性,旨在为临床提供基于性别的合理用药指导与参考,促进安全有效的药物治疗实践.方法:通过获取FDA不良事件报告系统(FDA adverse event reporting system,FAERS)数据库2004年1月—2024年3月收到的唑吡坦药品不良事件(Adverse event,AE)报告,采用报告比值比(Reporting odds ratio,ROR)数据挖掘方法进行信号挖掘,重点分析性别差异的信号强度.结果:对11 289例女性患者和7 470例男性患者以唑吡坦为主要药物的不良反应报告进行信号挖掘,共检测出32个阳性信号,男女各16个.女性易出现的不良反应包括:哭泣、寒战、偏头痛、荨麻疹、关节痛、瘙痒、腹部不适、感觉异常、呼吸过缓、腹泻、上腹痛、感觉减退、体重降低、妊娠过程中暴露、挫伤和心悸.男性易出现的不良反应包括:共济失调、异睡症、杀人意念、人身攻击行为、妄想、谵妄、顺行性遗忘、语无伦次、外周水肿、血肌酸磷酸激酶升高、丙氨酸氨基转移酶升高.此外,男性中药物误用/意外暴露、用药错误及自我药疗等不良事件也为较为多见.结论:唑吡坦的不良反应存在显著性别差异,女性患者更易出现情绪障碍、皮肤及超敏反应,建议慎用高剂量唑吡坦,男性患者则需重点监测暴力行为及认知功能损害等表现,临床用药应重视性别特异性风险评估.
Objective:To delve deeply into and assess the gender differences in adverse drug reaction(ADR)signals associated with zolpidem,aiming to provide gender-based rational drug use guidance and references for clinical practice and promote safe and effective drug therapy.Methods:Using data from the FDA adverse event reporting system(FAERS)database spanning from January 2004 to March 2024,reports of adverse events(AEs)associated with zolpidem were retrieved.The reporting odds ratio(ROR)method was employed for signal detection,with a specific focus on analyzing the signal intensity of gender-related differences.Results:A total of 11 289 female and 7 470 male patients with zolpidem as the primary drug were included in this study.Signal mining identified 32 positive signals,16 for each gender.Analysis revealed that females were more likely to experience adverse reactions such as crying,chills,migraine,urticaria,arthralgia,pruritus,abdominal discomfort,paraesthesia,bradypnoea,diarrhoea,abdominal pain upper,hypoaesthesia,weight decreased,exposure during pregnancy,contusion,and palpitations.Conversely,adverse reactions more frequently observed in males included hereditary ataxia,parasomnia,homicide,physical assault,delusion,delirium,anterograde amnesia,incoherent,oedema peripheral,increaing of blood creatine phosphokinase and alanine aminotransferase.Furthermore,adverse events such as product administration error,accidental exposure to product,wrong product administered,and self-medication were also found to be more prevalent among males.Conclusion:Sig-nificant sex-related differences in zolpidem-associated adverse drug reactions(ADRs).Female patients demonstrated higher susceptibility to emotional disturbances and dermatological reactions,suggesting cautious use of high-dose zolpi-dem in this population.Male patients required particular vigilance for monitoring violent behaviors and cognitive impair-ments.These findings underscore the clinical importance of sex-specific risk assessment in zolpidem pharmacotherapy.
曾春梅;凌芝
海军军医大学第一附属医院 上海长海医院介入治疗科,上海 200000海军军医大学第一附属医院 上海长海医院介入治疗科,上海 200000
医药卫生
唑吡坦不良事件报告比值比法性别差异药物警戒
ZolpidemAdverse eventReporting odds ratio methodSex-related diffeencePharmacovigilance
《赣南医科大学学报》 2026 (8)
736-742,7
评论